VCP-KIAA1539 Fusion FISH Probe
The VCP-KIAA1539 Fusion FISH Probe is used to confirm a fusion of the VCP and KIAA1539 genes. The fusion of the VCP and KIAA1539 genes has been associated with Adrenocortical Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| VCP-KIAA1539-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-RERE | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-REOR | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-REGO | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-REGR | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-OROR | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-GORE | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-GROR | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| VCP-KIAA1539-20-AQAQ | 20 (40 μL) | 200 μL |
|
VCP Gene Summary
This gene encodes a member of the AAA ATPase family of proteins. The encoded protein plays a role in protein degradation, intracellular membrane fusion, DNA repair and replication, regulation of the cell cycle, and activation of the NF-kappa B pathway. This protein forms a homohexameric complex that interacts with a variety of cofactors and extracts ubiquitinated proteins from lipid membranes or protein complexes. Mutations in this gene cause IBMPFD (inclusion body myopathy with paget disease of bone and frontotemporal dementia), ALS (amyotrophic lateral sclerosis) and Charcot-Marie-Tooth disease in human patients. [provided by RefSeq, Aug 2017]
Gene Name: Valosin Containing Protein
Chromosome: CHR9: 35056064 -35072739
Locus: 9p13.3
Gene Diseases
The VCP KIAA1539 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Adrenocortical Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|